Functional Testing of KLF7 in Spinal Cord Injury: An Optogenetic Approach

KLF7 在脊髓损伤中的功能测试:光遗传学方法

基本信息

  • 批准号:
    9067525
  • 负责人:
  • 金额:
    $ 32.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-15 至 2018-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The failure of axon regeneration in the central nervous system (CNS) prevents treatment of a wide range of CNS afflictions, including spinal cord injury, stroke, and diseases like Parkinson's. One major reason that regeneration fails is that many CNS undergo a developmental loss in their intrinsic capacity for axon growth. To restore function after CNS injury or disease it is essential that we devise means to enhance the intrinsic growth state of CNS neurons. We recently identified the Kr¿ppel-like family of transcription factors (KLFs) as key regulators of intrinsic regenerative capacity in CNS neurons. Critically, a transcriptionally active mutant, VP16-KLF7, promotes axon regeneration by injured corticospinal tract (CST) neurons, an important therapeutic target. Robust regenerative responses were achieved using viral delivery to adult wild-type animals, raising potential clinical relevance for this novel pro-regenerative tool. To further explore the potential of KLF7 activity t promote CNS regeneration, three key questions must be addressed, corresponding to our aims. First because recovery from SCI depends on multiple functional modalities carried by diverse fiber tracts, we will use viral-mediated gene delivery to test the ability of VP16-KLF7 to promote regeneration in additional neuronal populations. Targeting additional neuronal subtypes has the potential to broaden the range of behavioral improvement after SCI. Second, we will examine the expression of pro-regenerative genes in neurons stimulated by VP16-KLF7 in order to determine the potential relationship between with known pro-regenerative (e.g. mTOR, CNTF) or anti-regenerative (e.g. chondroitin sulfate proteoglycan (CSPG)) pathways and signals. Based on this information we will rationally combine VP16/KLF7 with viral particles that target complementary pathways, potentially inducing additive or synergistic improvements in axon regeneration. Finally, we will examine the extent to which KLF7-stimulated axons succeed in forming functional synapses on appropriate target cells and ultimately contribute to functional recovery. Using viral gene delivery we will co-express VP16- KLF7 with optogenetic constructs that enable the treated neurons to be reversibly activated or silenced. This technique will allow us to determine the specific contribution of the treated neurons to electrophysiological and behavioral output as regeneration proceeds. Taken together, these experiments have a strong potential to extend the use of a promising new pro-regenerative tool and lead to the development of novel combinatorial methods to promote axon regeneration and functional recovery in the injured CNS, leading to novel treatment options for people suffering from CNS afflictions.
描述(申请人提供):中枢神经系统(CNS)轴突再生失败阻碍了多种中枢神经系统疾病的治疗,包括脊髓损伤、中风和帕金森氏症等疾病。再生失败的一个主要原因是许多CNS轴突生长的内在能力发育丧失。为了在中枢神经系统损伤或疾病后恢复功能,我们必须设计手段来增强中枢神经系统神经元的内在生长状态。我们最近发现Kr?ppel样转录因子家族(KLF)是中枢神经系统神经元内在再生能力的关键调节因子。关键的是,转录活性突变体VP16-KLF7促进受损的皮质脊髓束(CST)神经元的轴突再生,这是一个重要的治疗靶点。通过将病毒传递给成年野生型动物,获得了强大的再生反应,提高了临床潜力 与这一新的促进再生工具的相关性。为了进一步挖掘KLF7活性促进中枢神经系统再生的潜力,必须解决与我们的目标相一致的三个关键问题。首先,由于脊髓损伤的康复依赖于不同纤维束携带的多种功能方式,我们将使用病毒介导的基因传递来测试VP16-KLF7促进额外神经元群体再生的能力。靶向其他神经元亚型有可能拓宽脊髓损伤后行为改善的范围。其次,我们将检测VP16-KLF7刺激的神经元中促再生基因的表达,以确定与已知的促再生(如mTOR,CNTF)或抗再生(如硫酸软骨素蛋白多糖(CSPG))通路和信号之间的潜在关系。基于这些信息,我们将合理地将VP16/KLF7与针对互补途径的病毒颗粒结合,潜在地诱导附加或协同改善轴突再生。最后,我们将检查KLF7刺激的轴突在多大程度上成功地在适当的靶细胞上形成功能性突触,并最终有助于功能恢复。利用病毒基因传递,我们将VP16-KLF7与光遗传构建物共表达,使处理后的神经元能够可逆地激活或沉默。这项技术将使我们能够确定随着再生的进行,经过处理的神经元对电生理和行为输出的具体贡献。综上所述,这些实验有很大的潜力扩大一种有前景的新的促再生工具的使用,并导致开发新的组合方法来促进受损中枢神经系统的轴突再生和功能恢复,从而为患有中枢神经系统疾病的人提供新的治疗方案。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Murray G Blackmore其他文献

Murray G Blackmore的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Murray G Blackmore', 18)}}的其他基金

Brain-wide transcriptional profiling after spinal cord injury
脊髓损伤后全脑转录谱分析
  • 批准号:
    10827193
  • 财政年份:
    2023
  • 资助金额:
    $ 32.92万
  • 项目类别:
Strategies to maximize the functional benefit of regenerated corticospinal tract axons
最大化再生皮质脊髓束轴突功能效益的策略
  • 批准号:
    10455666
  • 财政年份:
    2018
  • 资助金额:
    $ 32.92万
  • 项目类别:
Strategies to maximize the functional benefit of regenerated corticospinal tract axons
最大化再生皮质脊髓束轴突功能效益的策略
  • 批准号:
    10200919
  • 财政年份:
    2018
  • 资助金额:
    $ 32.92万
  • 项目类别:
The transcription factor HHEX as a novel regulator of CNS axon regeneration
转录因子 HHEX 作为中枢神经系统轴突再生的新型调节因子
  • 批准号:
    9018774
  • 财政年份:
    2015
  • 资助金额:
    $ 32.92万
  • 项目类别:
The transcription factor HHEX as a novel regulator of CNS axon regeneration
转录因子 HHEX 作为中枢神经系统轴突再生的新型调节因子
  • 批准号:
    9132364
  • 财政年份:
    2015
  • 资助金额:
    $ 32.92万
  • 项目类别:
Combinatorial Manipulation of Transcription Factors to Promote CNS Regeneration
转录因子的组合操作促进中枢神经系统再生
  • 批准号:
    9890010
  • 财政年份:
    2013
  • 资助金额:
    $ 32.92万
  • 项目类别:
Combinatorial Manipulation of Transcription Factors to Promote CNS Regeneration
转录因子的组合操作促进中枢神经系统再生
  • 批准号:
    10368049
  • 财政年份:
    2013
  • 资助金额:
    $ 32.92万
  • 项目类别:
Combinatorial Manipulation of Transcription Factors to Promote CNS Regeneration
转录因子的组合操作促进中枢神经系统再生
  • 批准号:
    10582546
  • 财政年份:
    2013
  • 资助金额:
    $ 32.92万
  • 项目类别:
Functional Testing of KLF7 in Spinal Cord Injury: An Optogenetic Approach
KLF7 在脊髓损伤中的功能测试:光遗传学方法
  • 批准号:
    8700555
  • 财政年份:
    2013
  • 资助金额:
    $ 32.92万
  • 项目类别:
Functional Testing of KLF7 in Spinal Cord Injury: An Optogenetic Approach
KLF7 在脊髓损伤中的功能测试:光遗传学方法
  • 批准号:
    8847417
  • 财政年份:
    2013
  • 资助金额:
    $ 32.92万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.92万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 32.92万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 32.92万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 32.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 32.92万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 32.92万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 32.92万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 32.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 32.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 32.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了